OXALIPLATIN EBW 150MG INJECTION

OXALIPLATIN EBW 150MG INJECTION contains Oxaliplatin as its active ingredient. Oxaliplatin is a chemotherapy medication used in the treatment of various cancers, including colorectal cancer and certain types of stomach cancer. It belongs to the class of platinum-based antineoplastic agents and works by inhibiting the growth and replication of cancer cells.

Uses:

OXALIPLATIN EBW 150MG INJECTION is prescribed for the treatment of colorectal cancer, either as adjuvant therapy (after surgery to prevent cancer recurrence) or as part of combination chemotherapy regimens for advanced or metastatic disease. It may also be used in the treatment of advanced gastric cancer in combination with other chemotherapeutic agents. Oxaliplatin works by causing DNA damage in cancer cells, leading to cell death and regression of tumors.

Administration:

OXALIPLATIN EBW 150MG INJECTION is administered intravenously by healthcare professionals in clinical settings such as hospitals or infusion centers. The dosage and frequency of administration are determined by the patient’s body surface area, medical history, and response to treatment. Treatment regimens may vary, but typically, Oxaliplatin is given in combination with other chemotherapy drugs, such as 5-fluorouracil (5-FU) and leucovorin.

Side Effects:

Common side effects of OXALIPLATIN EBW 150MG INJECTION may include nausea, vomiting, diarrhea, fatigue, peripheral neuropathy (numbness, tingling, or pain in the hands or feet), and myelosuppression (decreased production of blood cells). It may also cause more serious side effects such as allergic reactions, kidney damage, liver toxicity, or anemia. Patients should promptly report any adverse reactions to their healthcare provider.

Precautions:

Before using OXALIPLATIN EBW 150MG INJECTION, inform your healthcare provider about any pre-existing medical conditions, allergies, or medications you are currently taking. Special precautions may be necessary for individuals with kidney or liver problems, neuropathy, or those who are pregnant or breastfeeding. Close monitoring for adverse reactions during treatment is essential.

Contraindications:

OXALIPLATIN EBW 150MG INJECTION should not be used in patients with known hypersensitivity to Oxaliplatin or any of the components of the formulation. It should also be avoided in patients with severe renal impairment or those with a history of allergic reactions to platinum-based chemotherapy agents. Pregnant or breastfeeding women should not use Oxaliplatin due to potential harm to the fetus or infant.

Conclusion:

OXALIPLATIN EBW 150MG INJECTION, containing Oxaliplatin, is an important chemotherapy medication for the treatment of colorectal cancer and certain types of gastric cancer. While offering significant benefits in combating cancer, patients should be aware of potential side effects and follow their healthcare provider’s instructions for safe and effective use.